Your browser version may not work well with NCBI's Web applications. More information here...
1: Nat Cell Biol. 2006 Mar;8(3):285-92. Epub 2006 Feb 5.
Related Articles, Links
Click here to read Click here to read
Comment in:
The NuRD component Mbd3 is required for pluripotency of embryonic stem cells.

Kaji K, Caballero IM, MacLeod R, Nichols J, Wilson VA, Hendrich B.

Centre Development in Stem Cell Biology, Institute for Stem Cell Research, School of Biological Sciences, University of Edinburgh, Edinburgh, EH9 3JQ, Scotland, UK.

Cells of early mammalian embryos have the potential to develop into any adult cell type, and are thus said to be pluripotent. Pluripotency is lost during embryogenesis as cells commit to specific developmental pathways. Although restriction of developmental potential is often associated with repression of inappropriate genetic programmes, the role of epigenetic silencing during early lineage commitment remains undefined. Here, we used mouse embryonic stem cells to study the function of epigenetic silencing in pluripotent cells. Embryonic stem cells lacking Mbd3 - a component of the nucleosome remodelling and histone deacetylation (NuRD) complex - were viable but failed to completely silence genes that are expressed before implantation of the embryo. Mbd3-deficient embryonic stem cells could be maintained in the absence of leukaemia inhibitory factor (LIF) and could initiate differentiation in embryoid bodies or chimeric embryos, but failed to commit to developmental lineages. Our findings define a role for epigenetic silencing in the cell-fate commitment of pluripotent cells.

Publication Types:
PMID: 16462733 [PubMed - indexed for MEDLINE]